{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:28:15Z","timestamp":1783225695557,"version":"3.54.6"},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,4,25]]},"DOI":"10.1001\/jama.2023.2548","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T15:32:34Z","timestamp":1682436754000},"page":"1406","source":"Crossref","is-referenced-by-count":2,"title":["Review of Progress and Challenges in Bacterial Meningitis"],"prefix":"10.1001","volume":"329","author":[{"given":"Simone","family":"Giuliano","sequence":"first","affiliation":[{"name":"Infectious Diseases Clinic, Azienda Sanitaria Universitaria del Friuli Centrale (ASUFC), Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sbrana","sequence":"additional","affiliation":[{"name":"Lipoapheresis Unit and Reference Center for Inherited Dyslipidemias, Fondazione Toscana Gabriele Monasterio, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[{"name":"Department of Medical Area (DAME), University of Udine, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"21","key":"jle230023r1","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1001\/jama.2022.20521","article-title":"Progress and challenges in bacterial meningitis: a review.","volume":"328","author":"Hasbun","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"jle230023r3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13054-015-1021-7","article-title":"Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study.","volume":"19","author":"Bretonni\u00e8re","year":"2015","journal-title":"Crit Care"},{"key":"jle230023r4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jgar.2021.03.007","article-title":"In vitro antimicrobial activity of daptomycin alone and in adjunction with either amoxicillin, cefotaxime or rifampicin against the main pathogens responsible for bacterial meningitis in adults.","volume":"25","author":"Maldiney","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"jle230023r2","unstructured":"World Health Organization. Defeating Meningitis by 2030: A Global Road Map. Published June 24, 2021. Accessed June 24, 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240026407"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2804074\/jama_giuliano_2023_le_230023_1681934433.23256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T15:32:37Z","timestamp":1682436757000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2804074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":4,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,4,25]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.2548","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}